Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
[Cancer Research 59, 1449-1453, April 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carson, J. P.
Right arrow Articles by Weber, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carson, J. P.
Right arrow Articles by Weber, M. J.
[Cancer Research 59, 1449-1453, April 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Antiapoptotic Signaling in LNCaP Prostate Cancer Cells

A Survival Signaling Pathway Independent of Phosphatidylinositol 3'-Kinase and Akt/Protein Kinase B1

Jonathan P. Carson, George Kulik and Michael J. Weber2

Department of Microbiology and Cancer Center, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908

Constitutive activation of the phosphatidylinositol 3'-kinase (PI3 kinase)-Akt/protein kinase B (PKB) "survival signaling" pathway is a likely mechanism by which many cancers become refractory to cytotoxic therapy. In LNCaP prostate cancer cells, the PTEN phosphoinositide phosphatase is inactivated, leading to constitutive activation of Akt/PKB and resistance to apoptosis. However, apoptosis and inactivation of Akt/PKB can be induced in these cells by treatment with PI3 kinase inhibitors. Surprisingly, androgen, epidermal growth factor, or serum can protect these cells from apoptosis, even in the presence of PI3 kinase inhibitors and without activation of Akt/PKB, indicating the activity of a novel, Akt/PKB-independent survival pathway. This pathway blocks apoptosis at a level prior to caspase 3 activation and release of cytochrome c from mitochondria.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
Q.-S. Zhu, W. Ren, B. Korchin, G. Lahat, A. Dicker, Y. Lu, G. Mills, R. E. Pollock, and D. Lev
Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45{alpha}
Cancer Res., April 15, 2008; 68(8): 2895 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Zoubeidi, A. Zardan, E. Beraldi, L. Fazli, R. Sowery, P. Rennie, C. Nelson, and M. Gleave
Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity
Cancer Res., November 1, 2007; 67(21): 10455 - 10465.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. R. Cochrane, Z. Wang, M. Muramaki, M. E. Gleave, and C. C. Nelson
Differential Regulation of Clusterin and Its Isoforms by Androgens in Prostate Cells
J. Biol. Chem., January 26, 2007; 282(4): 2278 - 2287.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. R. Sastry, A. J. Smith, Y. Karpova, S. R. Datta, and G. Kulik
Diverse Antiapoptotic Signaling Pathways Activated by Vasoactive Intestinal Polypeptide, Epidermal Growth Factor, and Phosphatidylinositol 3-Kinase in Prostate Cancer Cells Converge on BAD
J. Biol. Chem., July 28, 2006; 281(30): 20891 - 20901.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Bertram, J. W. Peacock, C. Tan, A. L-F. Mui, S. W. Chung, M. E. Gleave, S. Dedhar, M. E. Cox, and C. J. Ong
Inhibition of the Phosphatidylinositol 3'-Kinase Pathway Promotes Autocrine Fas-Induced Death of Phosphatase and Tensin Homologue-Deficient Prostate Cancer Cells.
Cancer Res., May 1, 2006; 66(9): 4781 - 4788.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. A. Gomez, A. de las Pozas, and C. Perez-Stable
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Mol. Cancer Ther., May 1, 2006; 5(5): 1216 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Huh, A. Liepins, J. Zielonka, C. Andrekopoulos, B. Kalyanaraman, and A. Sorokin
Cyclooxygenase 2 Rescues LNCaP Prostate Cancer Cells from Sanguinarine-Induced Apoptosis by a Mechanism Involving Inhibition of Nitric Oxide Synthase Activity.
Cancer Res., April 1, 2006; 66(7): 3726 - 3736.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. T. Khan, L. Wagner II, D. I. Yule, C. Bhanumathy, and S. K. Joseph
Akt Kinase Phosphorylation of Inositol 1,4,5-Trisphosphate Receptors
J. Biol. Chem., February 10, 2006; 281(6): 3731 - 3737.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson
Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Endocr. Rev., December 1, 2005; 26(7): 898 - 915.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Gonzalez-Guerrico and M. G. Kazanietz
Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade: A KEY ROLE FOR PROTEIN KINASE C{delta}
J. Biol. Chem., November 25, 2005; 280(47): 38982 - 38991.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Ni, X. Wen, J. Yao, H.-C. Chang, Y. Yin, M. Zhang, S. Xie, M. Chen, B. Simons, P. Chang, et al.
Tocopherol-Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the Phosphoinositide 3-Kinase Pathway
Cancer Res., November 1, 2005; 65(21): 9807 - 9816.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Mohapatra, B. Chu, X. Zhao, and W.J. Pledger
Accumulation of p53 and Reductions in XIAP Abundance Promote the Apoptosis of Prostate Cancer Cells
Cancer Res., September 1, 2005; 65(17): 7717 - 7723.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
Z Culig, H Steiner, G Bartsch, and A Hobisch
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Endocr. Relat. Cancer, June 1, 2005; 12(2): 229 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
X. Liao, S. Tang, J. B. Thrasher, T. L. Griebling, and B. Li
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
Mol. Cancer Ther., April 1, 2005; 4(4): 505 - 515.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Krueckl, R. A. Sikes, N. M. Edlund, R. H. Bell, A. Hurtado-Coll, L. Fazli, M. E. Gleave, and M. E. Cox
Increased Insulin-Like Growth Factor I Receptor Expression and Signaling Are Components of Androgen-Independent Progression in a Lineage-Derived Prostate Cancer Progression Model
Cancer Res., December 1, 2004; 64(23): 8620 - 8629.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H.-K. Lin, Y.-C. Hu, D. K. Lee, and C. Chang
Regulation of Androgen Receptor Signaling by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Tumor Suppressor through Distinct Mechanisms in Prostate Cancer Cells
Mol. Endocrinol., October 1, 2004; 18(10): 2409 - 2423.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Kraus, G. Levy, T. Hanoch, Z. Naor, and R. Seger
Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: Role of c-Jun NH2-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways
Cancer Res., August 15, 2004; 64(16): 5736 - 5744.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Huang, D. C. Muddiman, and D. J. Tindall
Androgens Negatively Regulate Forkhead Transcription Factor FKHR (FOXO1) through a Proteolytic Mechanism in Prostate Cancer Cells
J. Biol. Chem., April 2, 2004; 279(14): 13866 - 13877.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. P. Carson, N. Zhang, G. M. Frampton, N. P. Gerry, M. E. Lenburg, and M. F. Christman
Pharmacogenomic Identification of Targets for Adjuvant Therapy with the Topoisomerase Poison Camptothecin
Cancer Res., March 15, 2004; 64(6): 2096 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-K. Lin, Y.-C. Hu, L. Yang, S. Altuwaijri, Y.-T. Chen, H.-Y. Kang, and C. Chang
Suppression Versus Induction of Androgen Receptor Functions by the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer LNCaP Cells with Different Passage Numbers
J. Biol. Chem., December 19, 2003; 278(51): 50902 - 50907.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Tanaka, M. V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M. G. Kazanietz
Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway
J. Biol. Chem., September 5, 2003; 278(36): 33753 - 33762.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-C. Yang, H.-P. Lin, C.-S. Chen, Y.-T. Yang, P.-H. Tseng, V. M. Rangnekar, and C.-S. Chen
Bcl-xL Mediates a Survival Mechanism Independent of the Phosphoinositide 3-Kinase/Akt Pathway in Prostate Cancer Cells
J. Biol. Chem., July 3, 2003; 278(28): 25872 - 25878.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai
AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR
Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. Gioeli, S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, et al.
Androgen Receptor Phosphorylation. REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES
J. Biol. Chem., August 2, 2002; 277(32): 29304 - 29314.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. A. Eid, R. W. Lewis, and M. V. Kumar
Mifepristone Pretreatment Overcomes Resistance of Prostate Cancer Cells to Tumor Necrosis Factor {alpha}-related Apoptosis-inducing Ligand (TRAIL)
Mol. Cancer Ther., August 1, 2002; 1(10): 831 - 840.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
Y. ZHANG, B. NAN, J. YU, T. SNABBOON, F. ANDRIANI, and M. MARCELLI
From Castration-Induced Apoptosis of Prostatic Epithelium to the Use of Apoptotic Genes in the Treatment of Prostate Cancer
Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 191 - 203.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. R. Jones, R. M. Broad, L. D. Comeau, S. J. Parsons, and M. W. Mayo
Inhibition of nuclear factor {kappa}B chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 310 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. P. Carson, M. Behnam, J. N. Sutton, C. Du, X. Wang, D. F. Hunt, M. J. Weber, and G. Kulik
Smac Is Required for Cytochrome c-induced Apoptosis in Prostate Cancer LNCaP Cells
Cancer Res., January 1, 2002; 62(1): 18 - 23.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Murillo, H. Huang, L. J. Schmidt, D. I. Smith, and D. J. Tindall
Role of PI3K Signaling in Survival and Progression of LNCaP Prostate Cancer Cells to the Androgen Refractory State
Endocrinology, November 1, 2001; 142(11): 4795 - 4805.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Chatterjee, K. H. Brite, and A. Matsumura
Induction of Apoptosis of Integrin-expressing Human Prostate Cancer Cells by Cyclic Arg-Gly-Asp Peptides
Clin. Cancer Res., October 1, 2001; 7(10): 3006 - 3011.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Chian, S. Young, A. Danilkovitch-Miagkova, L. Ronnstrand, E. Leonard, P. Ferrao, L. Ashman, and D. Linnekin
Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
Blood, September 1, 2001; 98(5): 1365 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Kimura, M. Markowski, C. Bowen, and E. P. Gelmann
Androgen Blocks Apoptosis of Hormone-dependent Prostate Cancer Cells
Cancer Res., July 1, 2001; 61(14): 5611 - 5618.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller
Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression
Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Jiang, Z. Wang, H. Ganther, and J. Lu
Caspases as Key Executors of Methyl Selenium-induced Apoptosis (Anoikis) of DU-145 Prostate Cancer Cells
Cancer Res., April 1, 2001; 61(7): 3062 - 3070.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Sumitomo, M. I. Milowsky, R. Shen, D. Navarro, J. Dai, T. Asano, M. Hayakawa, and D. M. Nanus
Neutral Endopeptidase Inhibits Neuropeptide-mediated Transactivation of the Insulin-like Growth Factor Receptor-Akt Cell Survival Pathway
Cancer Res., April 1, 2001; 61(8): 3294 - 3298.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
G. Kulik, J. P. Carson, T. Vomastek, K. Overman, B. D. Gooch, S. Srinivasula, E. Alnemri, G. Nunez, and M. J. Weber
Tumor Necrosis Factor {{alpha}} Induces BID Cleavage and Bypasses Antiapoptotic Signals in Prostate Cancer LNCaP Cells
Cancer Res., March 1, 2001; 61(6): 2713 - 2719.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
N. Nakamura, S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W. R. Sellers
Forkhead Transcription Factors Are Critical Effectors of Cell Death and Cell Cycle Arrest Downstream of PTEN
Mol. Cell. Biol., December 1, 2000; 20(23): 8969 - 8982.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J. Li, S. Yang, and T. R. Billiar
Cyclic Nucleotides Suppress Tumor Necrosis Factor alpha -Mediated Apoptosis by Inhibiting Caspase Activation and Cytochrome c Release in Primary Hepatocytes via a Mechanism Independent of Akt Activation
J. Biol. Chem., April 21, 2000; 275(17): 13026 - 13034.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Tang, C. P. Downes, A. D. Whetton, and P. J. Owen-Lynch
Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase
J. Biol. Chem., April 21, 2000; 275(17): 13142 - 13148.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Gewies, O. W. Rokhlin, and M. B. Cohen
Cytochrome c Is Involved in Fas-mediated Apoptosis of Prostatic Carcinoma Cell Lines
Cancer Res., April 1, 2000; 60(8): 2163 - 2168.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
L. Xue, J. H. Murray, and A. M. Tolkovsky
The Ras/Phosphatidylinositol 3-Kinase and Ras/ERK Pathways Function as Independent Survival Modules Each of Which Inhibits a Distinct Apoptotic Signaling Pathway in Sympathetic Neurons
J. Biol. Chem., March 17, 2000; 275(12): 8817 - 8824.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. W. Lee, C. L. Reimer, L. Fang, M. L. Iruela-Arispe, and S. A. Aaronson
Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression
Mol. Cell. Biol., March 1, 2000; 20(5): 1723 - 1732.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.-M. Georgescu, J. W. Simons, and G. L. Semenza
Modulation of Hypoxia-inducible Factor 1{{alpha}} Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics
Cancer Res., March 1, 2000; 60(6): 1541 - 1545.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. J. Moran, S. Gray, C. A. Mikosz, and S. D. Conzen
The Glucocorticoid Receptor Mediates a Survival Signal in Human Mammary Epithelial Cells
Cancer Res., February 1, 2000; 60(4): 867 - 872.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. D. Ebert, C. Wechselberger, S. Frank, B. Wallace-Jones, M. Seno, I. Martinez-Lacaci, C. Bianco, M. De Santis, H. K. Weitzel, and D. S. Salomon
Cripto-1 Induces Phosphatidylinositol 3'-Kinase-dependent Phosphorylation of AKT and Glycogen Synthase Kinase 3{beta} in Human Cervical Carcinoma Cells
Cancer Res., September 1, 1999; 59(18): 4502 - 4505.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Nesterov, X. Lu, M. Johnson, G. J. Miller, Y. Ivashchenko, and A. S. Kraft
Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis
J. Biol. Chem., March 30, 2001; 276(14): 10767 - 10774.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Li, S. V. Nicosia, and W. Bai
Antagonism between PTEN/MMAC1/TEP-1 and Androgen Receptor in Growth and Apoptosis of Prostatic Cancer Cells
J. Biol. Chem., June 1, 2001; 276(23): 20444 - 20450.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Belletti, M. Prisco, A. Morrione, B. Valentinis, M. Navarro, and R. Baserga
Regulation of Id2 Gene Expression by the Insulin-like Growth Factor I Receptor Requires Signaling by Phosphatidylinositol 3-Kinase
J. Biol. Chem., April 20, 2001; 276(17): 13867 - 13874.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.